A 78-year-old man with prostate cancer was referred for F-NaF PET/CT for assessing bone metastases. An F-NaF PET/CT study was performed after the intravenous administration of the radiopharmaceutical.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
Five days later, a second study was done after oral administration of the radiopharmaceutical as part of a research protocol.
Clinical nuclear medicine. 2015 Nov 06 [Epub ahead of print]
Samara Riguete Zacchi, Rômulo Hermeto Bueno do Vale, Paulo Schiavom Duarte, Marcelo Tatit Sapienza, Carlos Alberto Buchpiguel
From the Division of Nuclear Medicine, São Paulo Cancer Institute (ICESP), São Paulo, Brazil.